Russia and China to build a new pharmaceutical plant in the Irkutsk region
A Russian pharmaceutical company, in collaboration with Chinese partners, has announced the launch of a major investment project. The parties have agreed to build a new facility for the production of pharmaceutical substances, which will be located in the Irkutsk region.
The total cost of the project is estimated at 13.06 billion tenge. The investments will be directed toward creating a modern production site equipped with advanced machinery. It is expected that the plant will significantly expand the output of components necessary for the manufacture of medicinal products.
Cooperation with Chinese partners will help Russia strengthen its independence in the pharmaceutical sector. The use of foreign technology and expertise will allow for the establishment of high-quality raw material production within the country, which is particularly important for ensuring the stability of the medication market.
The construction of the plant will be an important step for the development of the regional economy. The project will not only create new jobs for residents of the Irkutsk region but will also help reduce dependence on imported pharmaceutical components in the future.